BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32869672)

  • 1. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
    Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
    Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.
    Heuser M; Mina A; Stein EM; Altman JK
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():411-420. PubMed ID: 31099617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.
    Reville PK; Kadia T
    Curr Treat Options Oncol; 2020 Apr; 21(4):34. PubMed ID: 32318829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel treatments for relapsed/refractory acute myeloid leukemia with
    Tallis E; Borthakur G
    Expert Rev Hematol; 2019 Aug; 12(8):621-640. PubMed ID: 31232619
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.
    Grieselhuber NR; Mims AS
    Curr Hematol Malig Rep; 2021 Apr; 16(2):192-206. PubMed ID: 33738705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.
    Sami SA; Darwish NHE; Barile ANM; Mousa SA
    Curr Treat Options Oncol; 2020 Jan; 21(1):3. PubMed ID: 31933183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia.
    Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine in acute myeloid leukemia: Hope, hype or both?
    Prasad V; Gale RP
    Leuk Res; 2016 Sep; 48():73-7. PubMed ID: 27497757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
    Naqvi K; Konopleva M; Ravandi F
    Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
    Schlenk RF; Döhner K; Döhner H
    Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on targeted therapies for acute myeloid leukaemia.
    Kayser S; Levis MJ
    Br J Haematol; 2022 Jan; 196(2):316-328. PubMed ID: 34350585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?
    Bewersdorf JP; Stahl M; Zeidan AM
    Leuk Lymphoma; 2019 Jun; 60(6):1354-1369. PubMed ID: 30652518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia transformed to a targetable disease.
    Saleh K; Khalifeh-Saleh N; Kourie HR
    Future Oncol; 2020 May; 16(14):961-972. PubMed ID: 32297538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving toward targeted therapies in acute myeloid leukemia.
    Gao W; Estey E
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.